pressed by 60±11 % after 2 h of hyperglycemia, and because this fall could not be entirely accounted for by decreased lactate extraction an inhibitory effect of glucose on gluconeogenesis within the liver is suggested. These studies indicate that the plasma glucose level per se can be an important determinant of the level of alanine and lactate in plasma as well as the rate at which they are converted to glucose.
INTRODUCTION
It has been generally accepted that alanine plays an important role in the transfer of nitrogen and carbon Dr. Liljenquist is an Investigator of the Howard Hughes Medical Institute.
Received for publication 9 Mllay 1979 and itn revised form 12 October 1979. 496 from extrahepatic tissues to the liver (1, 2) . Although numerous studies have been carried out in vitro to investigate both the release of alanine by muscle (3) (4) (5) (6) and the uptake of the amino acid by the liver (7) (8) (9) (10) , few such studies have been carried out in vivo. Chochinov et al. (11, 12) measured alanine flux in normal and diabetic subjects, while others have examined the effects of glucose infusion on splanchnic alanine uptake (13, 14) but it is clear that a systematic examination of the effects of the various factors (insulin, glucagon, and glucose) that might influence alanine flux in the whole animal has not been carried out.
Considerable evidence points toward a close relationship between the plasma glucose and alanine concentrations in vivo. The administration of large amounts of glucose, either intravenously (13) or orally (14) , results in substantial increases in the plasma alanine concentration. In certain conditions, often associated with abnormal carbohydrate metabolism, such as obesity and Cushing's syndrome, pronounced elevations in the plasma concentration of alanine are observed (15, 16) . Because the glycemic changes in the above states are associated with altered plasma levels of insulin and/or glucagon that might themselves affect alanine metabolism, (13, 14, 16) it has not been possible to deduce whether the changes in alanine concentration are caused by changes in the plasma levels of the pancreatic horm-ones, resistance to the actions of these hormones or secondary to changes in the plasma glucose concentration per se. Furthermore, it is not known whether the altered alanine levels are attributable to changes in the rate of appearance or disappearance of the amino acid from the vascular compartment.
Because the potential interaction between the pancreatic hormones and glucose in regulating the alanine concentration, the present studies were undertaken to examine the effect of hyperglycemia on total alanine flux and on alanine extraction by the liver. To define the effects of hyperglycemia independent of changes in insulin and/or glucagon secretion, the sugar was infused along with somatostatin (to inhibit the endocrine pancreas) and basal replacement amounts of insulin and glucagon. The results indicate that hyperglycemia per se exerts marked effects on alanine and lactate metabolism including the rate at which they are converted to glucose. At time zero, two separate protocols were initiated. Five dogs were given a peripheral saline infusion while a second set of dogs were infused with glucose in the mannier described previously (19) such that a step increment in plasma glucose concentration occurred.
NIETHODS
Collection and processing of blood samples. The collection and processing of blood samples has been described elsewhere (18) , as have the methods of immunoassay used for plasma insulin and glucagon (20, 21) AMaterials. [U-14C]alanine (New England Nuclear, Boston, Mass.) was used as the tracer (1 mCi/0.53 mg). By analysis using column chromatographic techniques it was determined that at least 99% ofthe counts infused were in alanine. Insulin and glucagon were purchased from Eli Lilly & Co., Indianapolis, Ind. Cyclic somatostatin was obtained from Bachem, Inc., Marina Del Rey, Calif. Indocyanine green was obtained from Hyson, Wescott and Dunning, Inc., Baltimore, Md. All hornmone solutions were prepared with normal saline and contained 0.3% bovine albumin.
Calculation1s. The balance of various substrates (lactate, alanine, and glucose) across the liver, the splanchnic bed and the nonhepatic splanchnic tissues (henceforth referred to as "gut") were calculated as described (17) . Similarly the coInversion of circulating alanine and lactate to glucose was calculated in the manner reported (18) . The rate of appearance (Ra)l anid rate of disappearance (Rd) ofalanine from the plasma were estimated by the method described for glucose (18) . The method is based on a single compartment analysis in which it is assumed that rapid changes in the specific activity and concentrations do not occur unifornly within the pool. To compensate for nonuniform mixing, the nonsteady-state term of the equation was multiplied by a correction fact of 0.65. Since the volume distribution of alanine is not well defined, for calculation purposes we have assumed it to be equal to the volume of distribution of glucose. The volume of distribution for glucose was measured using an injection of [3-3H] glucose at the beginning of each experiment as described (18) . Table I summarizes the combined control period alanine and lactate data from both experimental groups. It is evident that the portal vein specific activity of alanine was considerably lower (34%) than the specific activity of the amino acid in the artery. Because the ratio of the portal venous to arterial alanine specific activity was 0.66 and the ratio of the plasma alanine concentrations in the two vessels was 1.16, it is possible to calculate that about one-half of the dilution resulted from net addition of unlabeled alanine to the plasma and the remainder from exchange of labeled for unlabeled alanine as the plasma traversed the gut. To determine whether such exchange also took place across the liver the specific activity of alanine in plasma entering the liver was compared to that in plasma leaving the liver (Table II) . The ratio of the two specific activities did not differ significantly from unity, thus indicating that little if any exchange took place as the plasma traversed the liver.
RESULTS
I Abbreviations used in this paper: Ra, rate of appearance; Rd, rate of disappearance. It is interesting to note that the net amount of alanine added by the gut (0.7 ,mol/kg per min) was equivalent to 23% of the net alanine taken up by the liver. In addition, there was a wide disparity between the net rate of alanine uptake by the liver (3.1±0.2 ,umol/kg per min) and the total flux of alanine out of the plasma compartment as measured by isotope dilution (7.5±0.1 ,umol/kg per min). The mean rate of (14C]alanine infusion was 239 x 103 dpm/kg per min, whereas the mean rate of splanchnic uptake was 111 x 103 dpm/kg per min. Thus, only 46% of the infused ['4C]alanine was removed by the splanchnic bed, indicating that 54% of the alanine flux from the plasma was occurring at extrasplanchnic sites.
90 min after the infusion of [14C]alanine had begun, the arterial lactate specific activity was 13% of the arterial alanine specific activity (Table I ). There was a slight drop (8%) in the lactate specific activity across the gut and a significant increase (46%) across the liver.
The net amount oflactate added by the gut (1.8 gmol/kg per min) was equivalent to 24% of net lactate taken up by the liver (7.5 ,umol/kg per min). output (Table III) fell by -60% in response to the hyperglycemia as previously reported (19) . The effect of hyperglycemia per se on alanine metabolism can be seen in Fig. 2 the final concentration in the control group (210±18 ,tmol/liter). The rise in alanine was associated with a significant (P < 0.01 after 120 min) fall in the specific activity of the amino acid but little change in its radioactive concentration. Table IV shows that net alanine uptake by the liver Fig. 3 depicts the effect of hyperglycemia per se on the arterial concentration and specific activity of lactate, as well as on net hepatic lactate uptake. The rise in the plasma lactate concentration induced by hyperglycemia was significant (P < 0.05) from 60 min on, whether compared to the mean basal value or to the lactate level in control group. There was a slight difference in the lactate specific activities in the two groups but it was only significant during the last 15 min of the study. Fig. 3 also shows that hyperglycemia caused the hepatic extraction of lactate to fall to a level not significantly different from zero after 60-90 min. As a consequence of continued lactate production by the gut, the splanchnic bed as a whole actually pro- The increases in Ra and Rd attributable to hyperglycemia were significant (P < 0.05) during the last hour of the experiment. Values are means+SEM (n = 5). * Saline or glucose were infused from 0 to 120 min.
See Fig. 1 . and net hepatic uptake of lactate were significant (P < 0.05) from 90 min on when calculated using an unpaired t test and from 60 min on when calculated using a paired t test.
duced lactate during the last 30 inin of the sttudy (Table VI) . The data relating to [14C]glucose are shown in Fig. 4 . The specific activity of [14C]glucose was 6% of the specific activity of alanine during the control period. Its value was not stable at that time, however, and continued to rise throughout the course of the control experiments. Infusion of unlabeled glucose to achieve hyperglycemia caused both the specific activity and production rate of [14C]glucose to decrease markedly. In addition, the rate ofconversion ofcirculating alanin-e and lactate to glucose was suppressed to <40% ofits mean basal rate by the elevated blood glucose concentration.
Concentrations of individual amino acids in arterial plasma were determined by column chromatography in four out of five dogs that received glucose infusions. ception of alanine, also failed to change significantly throughout the course of the experiments (data not shown). 
DISCUSSION
The combination of arteriovenous difference and isotopic techniques used in these studies provided information that could not be gained by either technique alone. Catheterization of the artery as well as the portal and hepatic veins not only provided information concerning fluxes within the splanchnic bed, but also by isolating the splanchnic bed, allowed differentiation between the splanchnic and extrasplanchnic effects of hyperglycemia.
Basal splanchnic alanine exchange. The control period data indicate that the dilution of the alanine specific activity that has been reported to occur across the splanchnic bed in man (22) and the dog (23) organ, or bidirectional, but so rapid that the intracellular and plasma [14C]alanine specific activities are e(qual. Basal alanitne turtnover. Certain theoretical considerations of tracer methodology must be kept in mind when interpreting the alanine turnover data. The Ra of a substance in a given pool, or its e(quivalent of irreversable disposal, can be calculated under steadystate conditions usinig the plateau specific activity of the labeled moietv in the infused pool regardless of the configuration of the system or whether other sites of input and output exist (24) . The Ra cletermnined in this manner, hovever, is equivalent only to the rate of input of new trace to the pool sampled, and is not necessarily e(uivalent to the total turnover of the substances within the body, the latter being depenidenit uponl the mlodel assumiled for the system as a whole (24) . If production and usage are occ urrinig in an intracellular compartment, the determiinlationi of turnover in the central compartment (plasmna or extracellular space) will underestimate total turnover unless e(quilibrium between the extra and intracellular pools is so rapid that the specific activity is the same in both compartments (24) .
During the control period of the presenit studies the Ra and Rd of alanine were equal and were, as indicated above, a measure of the flux of new alanine into and out of the plasma compartmeent. Net alanine uptake by the liver equalled net alanine production by extrahepatic tissues, at that time, since the plasma alanine concentrationi was stable. While it would niot be expected that the total alanine flux and net entry of alanine into plasma wouldl be identical, it is of interest that the rate of total alanine flux was over twice the rate of net alanine entry into plasma. Furthermnore, >50% of total alanine efflux occurred in extrasplanchnic sites. As mentioned above, interpretationi of these findings is dependClenlt uponl the miodel assumned for the alaniine system. The current data caninot rtule out net transport of alanine from muscle to other extrasplanchnic organis as an explanation for the large turnover rate of the amino acid, but data in the literature suggest that other tissues such as the brain (25) and kidney (26, 27) As mlenitionied, the interpretationis of' these changes are depenidenit UpoIl the coimlpartimlent Imoldel assumiled for alaninie in vivo. If it is assumlled, as would be suggested by the studies across humian forearmii (28) , that much of' the observed flux of alaniine in the current stucdies was occurrinig in miiuscle then the data suggest that the increase in Ra was caused by an increase in intracellular alanine (pyruvate) turnover as well as increase in the net addition of' alanine to the plasma.
Because intracellular alanine is in rapid e(quilibriumn wvith pvruvate it is possible that the increased alaniine turnover actually reflects increased pyruvate turnover in the cell.
This in vivo dlemiionistrationi that hyperglycemia is capable of' increasing alaninle production is in agreement with the recenit in vitro studclies of' Chanig and Goldberg (3) (13, 14) in that iniereased cle novo synthesis of alaninie probably offsets dlecreased alaninie released fromii protein brought about by the anabolic effects of combined hyperglycemnia and hyperinsulinemia.
The failure of hyperglycemia to suppress net hepatic alanine uptake does not miiean that it was totally without effect onl alanine extraction by the liver. The rising conicentrationi of alaninie in the artery andl portal vein 502 Shuilmlnan, Laci/, Liljenqui.st, Keller, Williamins, atn(d Clmetrrinigtoni should have increased hepatic alanine extraction.2 The fact that this did not happen suggests that the efficiency of alanine removal by the liver was impaired, as indicated by a fall in the fractional extraction ofthe amino acid (20%) as well as a fall (16%) in overall alanine clearance. Although this fall was not the cause of the increase in the arterial alanine concentration, a decrease in the efficiency ofthe liver to extract alanine undoubtedly contributed to the continued rise in the concentration of the amino acid.
Felig et al. (13, 14) have shown that both intravenous and oral glucose acutely suppress net splanchnic alanine extraction in man. We have previously shown in dogs that the infusion of insulin with euglycemia maintained was without effect on splanchnic alanine extraction (29) . The present study also indicates that hyperglycemia in the presence of basal insulin and glucagon concentrations does not significantly suppress net hepatic alanine uptake. Taken as a whole these observations suggest that concomitant hyperglycemia and hyperinsulinemia are necessary to suppress net hepatic alanine extraction or that other factors, perhaps a decrease in the plasma glucagon level, are responsible for the observations of Felig et al. (13, 14) .
Interchange Hyperglycemia and lactate metabolism . After 2 h ofhyperglycemia the plasma lactate concentrations had doubled, primarily as a result of an almost complete cessation of lactate uptake by the liver. Whole blood lactate levels were not routinely determined, but in one experiment both plasma and whole blood were assayed for lactate and the changes in whole blood lactate were proportional to the changes in plasma lactate although basal lactate uptake by the liver was 27% higher when whole blood was used. The mechanism by which the change in net hepatic balance occurs is not known, but it is tempting to speculate that an elevated glucose concentration occurring in the absence of an appropriate insulin to glucagon molar ratio might lead to enhanced glycolysis and an increased level of lactate in the liver cell. Since the net movement of lactate into the liver is dependent upon its concentration gradient across the membrane the rise in intracellular lactate would impair its net uptake by hepatocytes. A similar inhibition of splanchnic lactate uptake was observed by Felig et al. (14) after glucose administration to man.
Hyperglycemia and the conversion of alanine and lactate to glucose. The method used for calculation of alanine and lactate conversion to glucose quantifies the rate of conversion of circulating arterial plasma alanine and lactate to plasma glucose. As previously discussed the method does not quantify total gluconeogenesis, nor can it identify a mechanism by which a change in conversion is brought about (18) . The data nevertheless indicate that the rate of conversion was reduced by 60% after the induction of hyperglycemia. This decrease could not be accounted for by deposition of [14C]glucose in glycogen since analysis of liver biopsies at the end of each experiment revealed that the glycogen present (18 mg/g tissue) was unlabeled. The current data indicate that part of the hyperglycemic effect on gluconeogenic conversion can be accounted for by the suppression of net hepatic lactate extraction. Only 20% ofthe 14C counts extracted by the liver during the control period were in lactate, however, so that complete suppression of the uptake of this precursor could only account for a 20% reduction in conversion. Because suppression of precursor conversion to glucose was much >20%, and because alanine uptake in absolute terms did not change, an additional intrahepatic effect of hyperglycemia is suggested. This could come about through an inhibition ofthe gluconeogenic pathway per se, or an enhancement of glycolysis that would also involve a dilution ofthe intracellular gluconeogenic precursor specific activity. Whether the cause of the decreased appearance of [14C]alanine in [14C]-glucose is direct inhibition of gluconeogenesis or stimulation of glycolysis it must reflect a decrease in the net flux of gluconeogenic carbon to glucose within the liver. Evidence is available from in vitro experiments to support the contention that glucose per se can inhibit gluconeogenesis (31) (32) (33) .
When interpreting the physiological significances of the current findings it should be borne in mind that the glucagon and insulin concentrations were kept constant and not allowed to vary appropriately in response to hyperglycemia. Whether the usual changes in these two hormones that normally accompany hyperglycemia would potentiate or inhibit the observed changes in alanine and lactate flux is not known. The data reported by O'Connell et al. (34) and Fitzpatrick et al. (35) that showed that glucose administration at high rates (intravenously or orally) increases the plasma alanine con-centration would suggest that the effects of hyperglycemia are not offset by concurrent changes in insulin or glucagon. Although Waterhouse and Kleison (36) were unable to detect an effect of glucose infusion on alanine metabolism in malnourished female subjects the rate of infusion was small and resulted in a glucose level of only about 125 mg/dl. In the one of their patients who received twice as much glucose the effect on alanine metabolism was entirely consistent with our observations.
The current data do not contradict the evidence that glucagon and insulin play important roles in the control of alanine and lactate metabolism in vivo. They suggest, however, that the plasma glucose level can itself also modify the metabolism of the two main gluconeogenic precursors. Hyperglycemia leads to an elevation in the plasma lactate concentration primarily as a consequence of decreased lactate uptake by the liver. In addition, it causes the plasma alanine level to rise as a result ofan increase in the production rate ofthe amino acid and a fall in its fractional extraction by the liver. Lastly, hyperglycemia not only alters the net rate of entry of the aforementioned gluconeogenic precursors into the liver, it also decreases the efficiency with which they are converted to glucose.
